Advances in Cancer Research (2023)

The clinical role of glycobiology on ovarian cancer progression

Authors: Rhyisa Armbrister, Laura Ochoa, Karen L. Abbott

DOI: 10.1016/bs.acr.2022.07.004PMID: 36725106

Overview & Significance

Discusses the role of glycans and glycoproteins in ovarian cancer progression and the potential diagnostic and therapeutic significance of cancer-associated glycan changes.

Glycobiology plays a crucial clinical role in understanding ovarian cancer progression. Alterations in protein glycosylation significantly impact tumor cell adhesion, migration, immune evasion, and drug resistance. This work explores cancer-associated glycan structures as potential biomarkers and therapeutic targets in epithelial ovarian cancer.

Key Research Concepts

Ovarian Cancer GlycobiologyProtein GlycosylationCancer BiomarkersTargeted TherapeuticsTumor Microenvironment